Clinical Trial: OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07153705) titled 'OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer' on Aug. 26.

Brief Summary: To study the performance of OCS products based on exosome detection technology in monitoring the recurrence of baseline CA125-negative ovarian cancer patients after initial treatment, and to explore reliable methods for monitoring the recurrence of baseline CA125-negative ovarian cancer patients after initial treatment.

Study Start Date: Sept. 01

Study Type: OBSERVATIONAL

Condition: Ovarian Cancer

Recruitment Status: NOT_YET_RECRUITING

Sponsor...